NCT06876805 The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods
| NCT ID | NCT06876805 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Focal Liver Lesion |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-08-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the study is to determine the accuracy of CEUS in characterizing (as benign or malignant) focal liver lesions for which CT, MRI and/or PET have not been conclusive.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years. * CEUS performed performed in the last 6 months a CT, MRI and/or PET not decisive in characterizing a liver lesion. * Obtaining informed consent. Exclusion Criteria: * Technical impossibility to perform the ultrasound evaluation. * Documented allergy to the ultrasound contrast medium.
Contact & Investigator
Carla Serra, PhD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06876805 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Focal Liver Lesion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06876805 currently recruiting?
Yes, NCT06876805 is actively recruiting participants. Contact the research team at carla.serra@aosp.bo.it for enrollment information.
Where is the NCT06876805 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06876805 clinical trial?
NCT06876805 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Carla Serra, PhD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 100 participants.